Effect of Continuous Subcutaneous Foslevodopa/foscarbidopa Treatment on Falls, Posture and Freezing of Gait

被引:0
|
作者
Odin, P. [1 ]
Kimura, T. [2 ]
Santos-Garcia, D. [3 ]
Gandor, F. [4 ]
Isaacson, S. [5 ]
Saad, A. [6 ]
Bergmann, L. [6 ]
Gupta, R. [6 ]
Kukreja, P. [6 ]
Shah, M. [6 ]
Pahwa, R. [7 ]
机构
[1] Lund Univ, Skane Univ Hosp, Div Neurol, Dept Clin Sci, Lund, Sweden
[2] Natl Hosp Org, Dept Neurol, Asahikawa Med Ctr, Asahikawa, Hokkaido, Japan
[3] Complejo Hospitalario Univ A Coruna, CHUAC, La Coruna, Spain
[4] Otto von Guericke Univ, Dept Neurol, Magdeburg, Germany
[5] Parkinsons Dis & Movement Disorders Ctr Boca Rato, Boca Raton, FL USA
[6] AbbVie Inc, North Chicago, CA USA
[7] Univ Kansas, Med Ctr, Kansas City, KS USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
EPR-281
引用
收藏
页码:312 / 312
页数:1
相关论文
共 44 条
  • [1] Effect of continuous subcutaneous foslevodopa/foscarbidopa treatment on falls, posture and freezing of gait
    Odin, P.
    Kimura, T.
    Santos-Garcia, D.
    Gandor, F.
    Isaacson, S.
    Saad, A.
    Bergmann, L.
    Gupta, R.
    Kukreja, P.
    Shah, M.
    Waern, J.
    Pahwa, R.
    AUSTRALASIAN JOURNAL ON AGEING, 2024, 43 : 31 - 32
  • [2] Foslevodopa/Foscarbidopa: A New Subcutaneous Treatment for Parkinson's Disease
    Rosebraugh, Matthew
    Voight, Eric A.
    Moussa, Ehab M.
    Jameel, Feroz
    Lou, Xiaochun
    Zhang, Geoff G. Z.
    Mayer, Peter T.
    Stolarik, Deanne
    Carr, Robert A.
    Enright, Brian P.
    Liu, Wei
    Facheris, Maurizio F.
    Kym, Philip R.
    ANNALS OF NEUROLOGY, 2021, 90 (01) : 52 - 61
  • [3] EFFECTS OF CONTINUOUS SUBCUTANEOUS INFUSION OF FOSLEVODOPA/FOSCARBIDOPA ON SLEEP DYSFUNCTION IN PEOPLE WITH PARKINSON'S
    Hauser, R.
    Bergmans, B.
    Malaty, I.
    Cobb, D.
    Homola, J.
    Bergmann, L.
    Gupta, R.
    Jia, J.
    Shah, M.
    Chaudhuri, K. R.
    PARKINSONISM & RELATED DISORDERS, 2024, 122
  • [4] Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson's disease: Considerations for initiation and maintenance
    Fung, Victor S. C.
    Aldred, Jason
    Arroyo, Martha P.
    Bergquist, Filip
    Boon, Agnita J. W.
    Bouchard, Manon
    Bray, Sarah
    Dhanani, Sara
    Facheris, Maurizio F.
    Fisseha, Nahome
    Freire-Alvarez, Eric
    Hauser, Robert A.
    Jeong, Anna
    Jia, Jia
    Kukreja, Pavnit
    Soileau, Michael J.
    Spiegel, Amy M.
    Talapala, Saritha
    Tarakad, Arjun
    Urrea-Mendoza, Enrique
    Zamudio, Jorge
    Pahwa, Rajesh
    CLINICAL PARKINSONISM & RELATED DISORDERS, 2024, 10
  • [5] Effects of continuous subcutaneous infusion of foslevodopa/foscarbidopa on quality-of-life in Parkinson's patients
    Gandor, F.
    Bouchard, M.
    Bergmans, B.
    Pahwa, R.
    Isaacson, S.
    Spiegel, A.
    Bergmann, L.
    Jia, J.
    Shah, M.
    Antonini, A.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 304 - 304
  • [6] Effects of continuous subcutaneous infusion of foslevodopa/foscarbidopa on quality-of-life in Parkinson's patients
    Gandor, F.
    Bouchard, M.
    Bergmans, B.
    Pahwa, R.
    Isaacson, S.
    Spiegel, A.
    Bergmann, L.
    Jia, J.
    Shah, M.
    Waern, J.
    Antonini, A.
    AUSTRALASIAN JOURNAL ON AGEING, 2024, 43 : 32 - 32
  • [7] Neutrophil-Rich Infusion Site Reactions After Continuous Subcutaneous Application of Foslevodopa/Foscarbidopa
    Weise, David
    Haferkamp, Sebastian
    MOVEMENT DISORDERS, 2025, 40 (02) : 389 - 390
  • [8] Skin Inflammatory Reactions in Patients with Continuous Subcutaneous Injection of Foslevodopa-Foscarbidopa Hydrate: Histopathology
    Yoshihara, Nagisa
    Nishikawa, Noriko
    Watanabe, Rei
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2025, 40 (02) : 378 - 379
  • [9] Continuous Subcutaneous Foslevodopa/Foscarbidopa: Final Results From a Phase 3, Open-Label Study
    Aldred, J.
    Amelin, A.
    Antonini, A.
    Bergmans, B.
    Bergquist, F.
    Bouchard, M.
    Budur, K.
    Carroll, C.
    Chaudhuri, K.
    Criswell, S.
    Danielsen, E.
    Alvarez, E. Freire
    Gandor, F.
    Jia, J.
    Kimber, T.
    Mochizuki, H.
    Robieson, W.
    Spiegel, A.
    Standaert, D.
    Talapala, S.
    Facheris, M.
    Fung, V.
    MOVEMENT DISORDERS, 2023, 38 : S8 - S8
  • [10] EFFICACY AND SAFETY OF FOSLEVODOPA/FOSCARBIDOPA CONTINUOUS SUBCUTANEOUS INFUSION ADMINISTERED AS MONOTHERAPY IN PATIENTS WITH PARKINSON'S DISEASE
    Aldred, J.
    Henriksen, T.
    Bouchard, M.
    Martinez-Castrillo, J. C.
    Soileau, M. J.
    Spiegel, A.
    Bergmann, L.
    Gupta, R.
    Kukreja, P.
    Standaert, D. G.
    PARKINSONISM & RELATED DISORDERS, 2024, 122